A comprehensive analysis of genomic determinants of response to immune checkpoint inhibitor-based immunotherapy.

被引：0
|
作者：
Yang, Jing [1 ]
Liu, Qi [1 ]
Shyr, Yu [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5018
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma
    Ha Il Kim
    Jihye Lim
    Ju Hyun Shim
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2069 - 2077
  • [22] Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis
    Lin, Xinqing
    Deng, Jiaxi
    Deng, Haiyi
    Yang, Yilin
    Sun, Ni
    Zhou, Maolin
    Qin, Yinyin
    Xie, Xiaohong
    Li, Shiyue
    Zhong, Nanshan
    Song, Yong
    Zhou, Chengzhi
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [23] Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma
    Shi, Fuyan
    Zhang, Wenjing
    Yang, Yichen
    Yang, Yitao
    Zhao, Junyi
    Xie, Mengqi
    Sheng, Chao
    Wang, Suzhen
    Wang, Qinghua
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [24] Promoted checkpoint inhibitor-based tumor immunotherapy by small-molecule prodrug hydrogelator
    Xu, Dongqing
    Wan, Fengyi
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [25] Eosinophilia in patients with melanoma under treatment with immune checkpoint inhibitor-based regimens
    Diamantopoulos, Panagiotis
    Gkoufa, Aikaterini
    Anastasopoulou, Amalia
    Kouzis, Panagiotis
    Ziogas, Dimitrios C.
    Kyriakakis, Georgios
    Gogas, Helen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs
    Capalbo, Carlo
    Scafetta, Giorgia
    Filetti, Marco
    Marchetti, Paolo
    Bartolazzi, Armando
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [27] Prognosis Factors in Advanced Lung Cancer Patients Treated With Checkpoint Inhibitor-Based Immunotherapy
    Wu, K.
    Zhang, M.
    Zhu, L.
    Wang, B.
    Xia, B.
    Ma, S.
    Chen, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1081 - S1082
  • [28] TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
    Reiter, Florian P.
    Geier, Andreas
    LANCET, 2025, 405 (10474): : 174 - 176
  • [29] Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
    Hung, Hao-Chien
    Lee, Jin-Chiao
    Wang, Yu-Chao
    Cheng, Chih-Hsien
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Wei-Chen
    CANCERS, 2021, 13 (07)
  • [30] Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
    Vos, Joris L.
    Traets, Joleen J. H.
    Qiao, Xiaohang
    Seignette, Iris M.
    Peters, Dennis
    Wouters, Michel W. J. M.
    Hooijberg, Erik
    Broeks, Annegien
    van der Wal, Jacqueline E.
    Karakullukcu, M. Baris
    Klop, W. Martin C.
    Navran, Arash
    van Beurden, Marc
    Brouwer, Oscar R.
    Morris, Luc G. T.
    van Poelgeest, Mariette I. E.
    Kapiteijn, Ellen
    Haanen, John B. A. G.
    Blank, Christian U.
    Zuur, Charlotte L.
    JCI INSIGHT, 2024, 9 (21)
12345